NCT03325166 2022-08-10Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain MetastasesOHSU Knight Cancer InstitutePhase 2 Terminated2 enrolled 8 charts